ESG for pharmaceutical Bring clarity to ESG across pharmaceutical operations
Connect environmental and social data across research, production, supply chains and people, so every site reports on the same basis.
Built for the rules Indian companies report to
BRSR- BRSR Core
CBAM
CCTS- CSRD
Why pharmaceutical leaders choose ESG Astraa
Every site on one basis
Labs, API plants and formulation units report energy, water and waste the same way, with the source file behind each figure.
- Sites reporting5/5
- Water meters logged18/18
- Waste manifests filed12/12
Close the cycle sooner
Owners, due dates and review in one place, so the BRSR cycle closes without chasing spreadsheets across plants.
6 weeks
to close the FY 2025-26 BRSR cycle
Supplier evidence on file
Suppliers of key starting materials answer short questionnaires and attach documents that wait for review.
Track water against a target
Set a water target per unit of output and follow each plant month by month against the FY 2025-26 baseline.
Next target
−8% water by FY 2027-28
From API plant to assured report in four steps
Measure every plant and lab
- Power, steam and chilled water logs come in from each API and formulation plant.
- Hazardous waste manifests and solvent recovery records are filed under the right indicator.
- Safety registers and LTIFR inputs are logged from every lab and plant each month.
Bring in your material suppliers
- Suppliers of key starting materials and intermediates answer a short questionnaire.
- Certificates, policies and energy data come attached to each answer.
- Supplier evidence is reviewed before it counts towards Scope 3 or BRSR value chain figures.
Cut water, solvent and steam use
- Compare plants on energy, water and waste per unit of output.
- Find where effluent treatment, steam or solvent use moves the totals most.
- Set targets against your FY 2025-26 baseline and track them monthly.
Report with a trail for auditors
- BRSR and BRSR Core from the same approved figures.
- CDP climate and water, EcoVadis and a GHG Protocol inventory, without re-keying data.
- Every reported total traces back to its site records for assurance.
Learn more about ESG in pharmaceutical
ESG Astraa Insights
Rules, deadlines and research for pharmaceutical in India, in plain words.
Read the insights
Rule changes, deadlines and new research for pharmaceutical. Short, and only when it matters.
FAQ
Common questions
Can we track ESG data across laboratories and facilities?
Yes. Each lab and plant enters or uploads its own data, and Astraa rolls it up by site, business unit and company, so every total traces back to its records.
How can we organise supplier evidence?
Suppliers answer short questionnaires and attach their documents, each with an owner and a due date. The evidence stays with the answer and waits for review before it counts.
Can we monitor safety and resource metrics?
Yes. Energy, water, waste and safety figures are tracked per site and per month. You can compare sites on the same measures and see where a figure has moved.
Ready for a clearer view of ESG in pharmaceutical?
See how ESG Astraa can help your team organise data, understand priorities and track progress.
Other industries
- Automotive
- Food & Beverage
- Tech & IT
- Chemicals
- Manufacturing
- Construction
- Electronic Goods
- Finance
- Retail
- and many more
Tell us about your industry and we will tell you how to turn sustainability into a competitive advantage. Email us at support@esgastraa.com